Trials / Terminated
TerminatedNCT02856477
Pharmacogenetic and Antidepressant Treatment in Elderly
Pharmacogenetic in the Therapeutic Strategy in Depressed Elderly
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to assess the therapeutic benefits of the adaptation of the antidepressant dose to the metabolic capacity (cytochrome P450 2D6) of elderly depressed patients. Therapeutic benefits are evaluated through the enhancement of efficiency, decrease of the action time and the after effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | urine analysis | a sample of urine is collected during 8 hours. |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-08-04
- Last updated
- 2016-08-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02856477. Inclusion in this directory is not an endorsement.